skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
previous page 1 Resultados 2
Refinado por: Nome da Publicação: Cancer remover assunto: Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Targeting mTOR in renal cell carcinoma
Targeting mTOR in renal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting mTOR in renal cell carcinoma

Hudes, Gary R.

Cancer, 2009-05, Vol.115 (S10), p.2313-2320 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
12
Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma
Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma

Kapoor, Anil ; Figlin, Robert A.

Cancer, 2009-08, Vol.115 (16), p.3618-3630 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
13
A phase 2 study of epothilone B analog BMS‐247550 (NSC 710428) in patients with relapsed aggressive non‐Hodgkin lymphomas
A phase 2 study of epothilone B analog BMS‐247550 (NSC 710428) in patients with relapsed aggressive non‐Hodgkin lymphomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 study of epothilone B analog BMS‐247550 (NSC 710428) in patients with relapsed aggressive non‐Hodgkin lymphomas

Churpek, Jane E. ; Pro, Barbara ; van Besien, Koen ; Kline, Justin ; Conner, Kathy ; Wade, James L. ; Hagemeister, Fredrick ; Karrison, Theodore ; Smith, Sonali M.

Cancer, 2013-05, Vol.119 (9), p.1683-1689 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
14
AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia
AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

Cooper, Todd M. ; Alonzo, Todd A. ; Gerbing, Robert B. ; Perentesis, John P. ; Whitlock, James A. ; Taub, Jeffrey W. ; Horton, Terzah M. ; Gamis, Alan S. ; Meshinchi, Soheil ; Loken, Michael R. ; Razzouk, Bassem I.

Cancer, 2014-08, Vol.120 (16), p.2482-2489 [Periódico revisado por pares]

Hoboken, NJ: Wiley-Blackwell

Texto completo disponível

Citações Citado por
15
Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status: Final Results of a Phase 2 Study (Burkimab)
Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status: Final Results of a Phase 2 Study (Burkimab)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status: Final Results of a Phase 2 Study (Burkimab)

RIBERA, Josep-Maria ; GARCIA, Olga ; GARCIA, Daniel ; BRUNET, Salut ; ALONSO, Natalia ; BARBA, Pere ; MIRALLES, Pilar ; LLORENTE, Andreu ; MONTESINOS, Pau ; MORENO, Maria-José ; HERNANDEZ-RIVAS, Jose-Angel ; BERNAL, Teresa ; GRANDE, Carlos ; ESTEVE, Jordi ; ORIOL, Albert ; BERGUA, Juan ; GONZALEZ-CAMPOS, Jose ; VALL-ILOVERA, Ferran ; TORMO, Mar ; HERNANDEZ-RIVAS, Jesus-Maria

Cancer, 2013-05, Vol.119 (9), p.1660-1668 [Periódico revisado por pares]

Hoboken, NJ: Wiley-Blackwell

Texto completo disponível

Citações Citado por
16
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high‐risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high‐risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities
Material Type:
Artigo 		Adicionar ao Meu Espaço

Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high‐risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities

Ravandi, Farhad ; Issa, Jean‐Pierre ; Garcia‐Manero, Guillermo ; O'Brien, Susan ; Pierce, Sherry ; Shan, Jianqin ; Borthakur, Gautam ; Verstovsek, Srdan ; Faderl, Stefan ; Cortes, Jorge ; Kantarjian, Hagop

Cancer, 2009-12, Vol.115 (24), p.5746-5751 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
17
High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years
High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years
Material Type:
Artigo 		Adicionar ao Meu Espaço

High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years

Arellano, Martha ; Winton, Elliott ; Pan, Lin ; Lima, Lisa ; Tighiouart, Mourad ; Bhalla, Kapil ; Heffner, Leonard T. ; Neely, Jessica ; Hutcherson, Donald ; McLemore, Morgan ; Langston, Amelia ; Khoury, H. Jean

Cancer, 2012-01, Vol.118 (2), p.428-433 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
18
Recommendations for the use of Yttrium‐90 ibritumomab tiuxetan in malignant lymphoma
Recommendations for the use of Yttrium‐90 ibritumomab tiuxetan in malignant lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Recommendations for the use of Yttrium‐90 ibritumomab tiuxetan in malignant lymphoma

Weigert, Oliver ; Illidge, Tim ; Hiddemann, Wolfgang ; Dreyling, Martin

Cancer, 2006-08, Vol.107 (4), p.686-695 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.